---
title: "Citi Sticks to Its Hold Rating for Amgen (AMGN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292817461.md"
description: "Citi analyst Geoff Meacham maintained a Hold rating on Amgen (AMGN) with a $345 price target. This follows similar Hold ratings from Wells Fargo, while Bank of America reiterated a Sell rating. The report also highlights TipRanks' new ETF (NYSE:RANK) and notes Meacham's strong track record in the healthcare sector."
datetime: "2026-07-15T20:37:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292817461.md)
  - [en](https://longbridge.com/en/news/292817461.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292817461.md)
generator: "portal-rs"
---

# Citi Sticks to Its Hold Rating for Amgen (AMGN)

Citi analyst Geoff Meacham maintained a Hold rating on Amgen today and set a price target of $345.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Meacham covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Merck & Company, and Pfizer. According to TipRanks, Meacham has an average return of 14.3% and a 58.58% success rate on recommended stocks. 

In addition to Citi, Amgen also received a Hold from Wells Fargo’s Mohit Bansal in a report issued on July 13. However, on the same day, Bank of America Securities reiterated a Sell rating on Amgen (NASDAQ: AMGN).

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)

## Related News & Research

- [TD Cowen Keeps Their Buy Rating on Amgen (AMGN)](https://longbridge.com/en/news/298357051.md)
- [What's Going On With Amgen Stock Tuesday?](https://longbridge.com/en/news/298350093.md)
- [Nilsine Partners LLC Makes New Investment in Amgen Inc. $AMGN](https://longbridge.com/en/news/298130227.md)
- [Sequoia Financial Advisors LLC Boosts Stock Holdings in Amgen Inc. $AMGN](https://longbridge.com/en/news/298575494.md)
- [Imdelltra’s Phase III Success in ES-SCLC Underpins Matt Phipps’ Buy Rating on Amgen](https://longbridge.com/en/news/298345109.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**